Compositions and methods for reprogramming diseased musculoskeletal cells
Disclosed herein are compositions and methods for reprogramming diseased musculoskeletal cells both in vitro and in vivo. In some embodiments, the disclosed method involves non-virally delivering intracellularly into the diseased musculoskeletal cells a polynucleotide comprising one or more nucleic acid sequences encoding one or more of the disclosed transcription factors.
1 . A method for treating a musculoskeletal disease intervertebral disc (IVD) degeneration in a mammalian subject, comprising injecting into the IVD of the mammalian subject
(a) a first extracellular vesicle produced from a donor cell containing or expressing T-box family protein and a Forkhead-box (FOX) family protein;
(b) a second extracellular vesicle produced from a cell containing or expressing a Mohawk family protein and Scleraxis.
2 . The method of claim 1 , wherein the first extracellular vesicle is produced from a cell containing or expressing a T-box family protein, a SOX family protein, and a Forkhead box (FOX) FOX family protein.
3 . The method of claim 1 , wherein the first extracellular vesicle is produced from a cell comprising a polynucleotide comprising FOXF1, Brachyury, and Sox9 genes operably linked to an expression control sequence.
4 . The method of claim 3 , wherein the second extracellular vesicle is produced from a cell comprising a polynucleotide comprising Mohawk and Scleraxis genes operably linked to an expression control sequence.
5 . The method of claim 1 , wherein the T-box family protein is Brachyury.
6 . The method of claim 1 , wherein the donor cell is a musculoskeletal cell or skin cell.
7 . The method of claim 1 , wherein the donor cell is a nucleus pulposus (NP) cell, annulus fibrosis (AF) cell, cartilage endplate cell, articular chondrocyte, tenocyte, or osteoblast.